Lv1
10 积分 2024-04-08 加入
T-cell dependency of tumor regressions and complete responses with RAS(ON) multi-selective inhibition in preclinical models of PDAC
1个月前
已完结
‘Undruggable’ cancer proteins meet their match
1个月前
已关闭
Pan-RAS inhibitor daraxonrasib shows promise in pancreatic cancer
1个月前
已完结
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
1个月前
已完结
Disrupted molecular glue complex drives RAS inhibitor resistance
1个月前
已完结
皖公网安备34019202002308
